UnknownNot Applicable

Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy

Sweden73 participantsStarted 2022-02-01

Plain-language summary

The purpose of this study is to evaluate neurotomy as an alternative treatment to Botox injections for severe synkinesis following peripheral facial palsy

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Synkinesis following peripheral facial palsy * Sunnybrook score \<61 * Botox injections at least 3 times a year * Have received at least 3 Botox injections * Botox injections not satisfying treatment * Read and signed written consent Exclusion Criteria: * Synkinesis since less than 2 years * Contractures in facial muscles * Other planned surgery in the face during study period * Smoking * Uncontrolled hypertension * Diabetes mellitus * Pregnancy or breast feeding * Severe systemic disease (ASA 3-4)

What they're measuring

Sunnybrook facial grading scale

Timeframe: Baseline, 4 months after Botox (no effect), 2-4 weeks after Botox (max effect), 6 and 12 months after surgery

Trial details

NCT IDNCT05191719

SponsorRebecka Ohm

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02

Contact for this trial

Rebecka Ohm, MD, PhDStud.

+4651770000 rebecka.ohm@regionstockholm.se

View on ClinicalTrials.gov More Facial Paralysis trials